Literature DB >> 20190480

A pleuro-peritoneal communication through the diaphragm affected with lymphangioleiomyomatosis.

Yumiko Takagi1, Teruhiko Sato, Yoshiteru Morio, Toshio Kumasaka, Keiko Mitani, Hideaki Miyamoto, Shin-Ichiro Iwakami, Yuzo Kodama, Emi Onuma, Kuniaki Seyama, Kazuhisa Takahashi.   

Abstract

A 30-year-old Japanese woman with lymphangioleiomyomatosis (LAM) developed a left chylothorax and chylous ascites. A pleuro-peritoneal communication was confirmed by a scintigram with (99)mTc-labeled macroaggregated-albumin injected into the peritoneal cavity. Video-assisted thoracic surgery revealed a protruding papillary lesion on the left diaphragm. Chyle was oozing into the pleural cavity through this lesion. Histopathological analyses demonstrated that the protrusion was a diaphragmatic LAM lesion and that LAM-associated lymphangiogenesis enabled communication between the pleural and peritoneal cavities through lymphatic vessels. This case demonstrated a new mechanism for chylous pleural effusion in LAM and illustrates the significance of LAM-associated lymphangiogenesis.

Entities:  

Mesh:

Year:  2010        PMID: 20190480     DOI: 10.2169/internalmedicine.49.2714

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Diagnosis and management of congenital neonatal chylous ascites.

Authors:  V Mouravas; O Dede; H Hatziioannidis; I Spyridakis; A Filippopoulos
Journal:  Hippokratia       Date:  2012-04       Impact factor: 0.471

2.  VATS therapy of chylothorax caused by leiomyomatosis complicated with tuberous sclerosis complex.

Authors:  Adrienn Csiszkó; György Herr; Sándor Sz Kiss; Judit Hallay; Zoltán Gyöngyösi; Zsolt Szentkereszty
Journal:  J Minim Access Surg       Date:  2013-04       Impact factor: 1.407

3.  Chylothorax secondary to a pleuroperitoneal communication and chylous ascites after pancreatic resection.

Authors:  Kazuki Hayashi; Jun Hanaoka; Yasuhiko Ohshio; Tomoyuki Igarashi
Journal:  J Surg Case Rep       Date:  2019-01-24

4.  Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis.

Authors:  Masashi Namba; Takeshi Masuda; Takashi Nakamura; Yasushi Horimasu; Shintaro Miyamoto; Taku Nakashima; Hiroshi Iwamoto; Kazunori Fujitaka; Hironobu Hamada; Noboru Hattori
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.